Skip to main content
. 2017 Jan 28;19(3):145–153. doi: 10.1016/j.neo.2016.12.005

Figure 1.

Figure 1

Combination of HNHA and sorafenib suppressed ATC cell proliferation more efficiently than either agent alone. Cell viability and proliferation assay of HNHA and sorafenib combined and HNHA and sorafenib alone in ATC cells (8505C, A and B; SNU-80, C and D; GSA1, E and F). Points indicate mean % of the value observed in the solvent-treated control. All experiments were repeated at least 3 times. The data represent the mean ± SD. Experiments were repeated at least 3 times with similar results. * P < .05 vs. control, ** P < .01 vs. control, *** P < .005 vs. control.